Home › Funds › Occam Crest Management LP › PGEN
Occam Crest Management LP position in PGEN
PRECIGEN INC · Health Care
Occam Crest Management LP reported holding 2,721,521 shares of PGEN (PRECIGEN INC) in its Q3 2026 13F filing — a position valued at US$23.3M, representing 13.14% of its reported portfolio and ranking #1 among its reported holdings. Occam Crest Management LP has disclosed PGEN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Occam Crest Management LP's PGEN position evolved
Occam Crest Management LP first disclosed a stake in PGEN in Q3 2025 at 2,000 shares (US$658K). The position peaked in Q3 2026 at 2,721,521 shares, worth US$23.3M. Across 5 filings, Occam Crest Management LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,721,521 shares valued at US$23.3M — an increase of 2,686,021 shares quarter over quarter.. Notable position changes include a 174987% increase in Q4 2025 (shares fell 7% over the following quarter), a 99% trim in Q2 2026 (shares rose 50% over the following quarter), a 7566% increase in Q3 2026 (shares fell 47% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 2.00K | $658.00K | New |
| Q4 2025 | 3.50M | $14.64M | Add |
| Q1 2026 | 4.27M | $16.52M | Add |
| Q2 2026 | 35.50K | $2.49M | Reduce |
| Q3 2026 | 2.72M | $23.30M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PGEN and 13F data
PGEN (PRECIGEN INC) is a Health Care company. 68 other funds we track also report a position in PGEN — the largest reported positions include Patient Capital Management, LLC (US$153.7M), TANG CAPITAL MANAGEMENT LLC (US$36.6M), Boxer Capital Management, LLC (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PGEN
- Patient Capital Management, LLC 17.95M sh · $153.65M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 6.42M sh · $36.58M · Q2 2026
- Boxer Capital Management, LLC 5.15M sh · $29.36M · Q2 2026
- IRIDIAN ASSET MANAGEMENT LLC/CT 3.06M sh · $26.23M · Q3 2026
- Diametric Capital, LP 1.41M sh · $8.05M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 683.42K sh · $5.85M · Q3 2026
- LexAurum Advisors, LLC 633.53K sh · $5.42M · Q3 2026
- Lansing Street Advisors 498.52K sh · $4.27M · Q3 2026
- GMT CAPITAL CORP 668.83K sh · $3.81M · Q2 2026
- Virtus Investment Advisers, LLC 378.76K sh · $3.24M · Q3 2026
More on Occam Crest Management LP
FAQ
How long has Occam Crest Management LP held PGEN?
Occam Crest Management LP has disclosed PGEN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Occam Crest Management LP's current position in PGEN?
As of Q3 2026, Occam Crest Management LP holds 2.72M shares of PGEN (PRECIGEN INC), valued at $23.30M, representing 13.14% of its reported portfolio and ranking #1.
Has Occam Crest Management LP been buying or selling PGEN?
In the latest 13F filing (Q3 2026), Occam Crest Management LP increased its position in PGEN. The position peaked in Q3 2026 at 2.72M shares.
Which other funds hold PGEN?
Other major institutional holders of PGEN include Patient Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Boxer Capital Management, LLC, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.